PARATHYROID HORMONE RELATED PEPTIDE HYPERCALCEMIA AS A PRESENTATION OF ENDOMETRIAL CLEAR CELL CARCINOMA

Authors

Claudia Georges, Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, United States of America.Follow
Biplov Adhikari, Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, United States of America.
Soumya Koundaveety, Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, United States of America.
Robert Jones, Department of Pathology, MedStar Franklin Square Medical Center, Baltimore, MD, United States of America.
Kalyan Paudel, Department of Radiology, MedStar Harbor Hosptial, Baltimore, MD, United States of America
Christopher Haas, Department of Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, MD, United States of America

Abstract

Hypercalcemia is a frequent complication of solid tumors and hematologic malignancies yet is only rarely associated with endometrial clear cell carcinoma. Here we report on a 70-year-old female who presented in the context of hip fracture and was incidentally found to have humoral hypercalcemia of malignancy secondary to endometrial clear cell carcinoma. This rare association makes endometrial cancer one of the differential diagnoses to be considered when assessing incidentally found symptomatic or asymptomatic hypercalcemia in the appropriate patient population.

Recommended Citation

Georges, Claudia; Adhikari, Biplov; Koundaveety, Soumya; Jones, Robert; Paudel, Kalyan; and Haas, Christopher (2023) "PARATHYROID HORMONE RELATED PEPTIDE HYPERCALCEMIA AS A PRESENTATION OF ENDOMETRIAL CLEAR CELL CARCINOMA," Journal of Community Hospital Internal Medicine Perspectives: Vol. 13: Iss. 6, Article 16.
DOI: 10.55729/2000-9666.1271
Available at: https://scholarlycommons.gbmc.org/jchimp/vol13/iss6/16